» Articles » PMID: 26344059

Validating Novel Tau Positron Emission Tomography Tracer [F-18]-AV-1451 (T807) on Postmortem Brain Tissue

Abstract

Objective: To examine region- and substrate-specific autoradiographic and in vitro binding patterns of positron emission tomography tracer [F-18]-AV-1451 (previously known as T807), tailored to allow in vivo detection of paired helical filament-tau-containing lesions, and to determine whether there is off-target binding to other amyloid/non-amyloid proteins.

Methods: We applied [F-18]-AV-1451 phosphor screen autoradiography, [F-18]-AV-1451 nuclear emulsion autoradiography, and [H-3]-AV-1451 in vitro binding assays to the study of postmortem samples from patients with a definite pathological diagnosis of Alzheimer disease, frontotemporal lobar degeneration-tau, frontotemporal lobar degeneration-transactive response DNA binding protein 43 (TDP-43), progressive supranuclear palsy, corticobasal degeneration, dementia with Lewy bodies, multiple system atrophy, cerebral amyloid angiopathy and elderly controls free of pathology.

Results: Our data suggest that [F-18]-AV-1451 strongly binds to tau lesions primarily made of paired helical filaments in Alzheimer brains (eg, intraneuronal and extraneuronal tangles and dystrophic neurites), but does not seem to bind to a significant extent to neuronal and glial inclusions mainly composed of straight tau filaments in non-Alzheimer tauopathy brains or to lesions containing β-amyloid, α-synuclein, or TDP-43. [F-18]-AV-1451 off-target binding to neuromelanin- and melanin-containing cells and, to a lesser extent, to brain hemorrhagic lesions was identified.

Interpretation: Our data suggest that [F-18]-AV-1451 holds promise as a surrogate marker for the detection of brain tau pathology in the form of tangles and paired helical filament-tau-containing neurites in Alzheimer brains but also point to its relatively lower affinity for lesions primarily made of straight tau filaments in non-Alzheimer tauopathy cases and to the existence of some [F-18]-AV-1451 off-target binding. These findings provide important insights for interpreting in vivo patterns of [F-18]-AV-1451 retention.

Citing Articles

F-MK-6240 tau PET in patients at-risk for chronic traumatic encephalopathy.

Alosco M, Mejia Perez J, Culhane J, Shankar R, Nowinski C, Bureau S Mol Neurodegener. 2025; 20(1):23.

PMID: 39994806 PMC: 11852567. DOI: 10.1186/s13024-025-00808-1.


Distinctive associations between plasma p-tau181 levels and hippocampal subfield volume across the Alzheimer's disease continuum.

Rich A, Oh H bioRxiv. 2025; .

PMID: 39975208 PMC: 11838288. DOI: 10.1101/2025.01.27.635113.


PET Imaging of a Transgenic Tau Rat Model SHR24 with [F]AV1451.

Ramakrishnan N, Zhao A, Thompson S, Milicevic Sephton S, Williamson D, Smolek T Mol Imaging Biol. 2025; .

PMID: 39838233 DOI: 10.1007/s11307-024-01972-4.


Essential tremor with tau pathology features seeds indistinguishable in conformation from Alzheimer's disease and primary age-related tauopathy.

Saez-Calveras N, Vaquer-Alicea J, White 3rd C, Tak Y, Cosentino S, Faust P Acta Neuropathol. 2025; 149(1):6.

PMID: 39775287 PMC: 11711841. DOI: 10.1007/s00401-024-02843-6.


Locus coeruleus tau is linked to successive cortical tau accumulation.

Yi D, Byun M, Jung J, Jung G, Ahn H, Chang Y Alzheimers Dement. 2024; 21(2):e14426.

PMID: 39641328 PMC: 11848382. DOI: 10.1002/alz.14426.


References
1.
SantaCruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M . Tau suppression in a neurodegenerative mouse model improves memory function. Science. 2005; 309(5733):476-81. PMC: 1574647. DOI: 10.1126/science.1113694. View

2.
Koeppen A, Michael S, Li D, Chen Z, Cusack M, Gibson W . The pathology of superficial siderosis of the central nervous system. Acta Neuropathol. 2008; 116(4):371-82. DOI: 10.1007/s00401-008-0421-z. View

3.
Van Nostrand W, Melchor J, Cho H, Greenberg S, Rebeck G . Pathogenic effects of D23N Iowa mutant amyloid beta -protein. J Biol Chem. 2001; 276(35):32860-6. DOI: 10.1074/jbc.M104135200. View

4.
Armstrong M, Litvan I, Lang A, Bak T, Bhatia K, Borroni B . Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013; 80(5):496-503. PMC: 3590050. DOI: 10.1212/WNL.0b013e31827f0fd1. View

5.
Lewis D, Campbell M, Terry R, Morrison J . Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci. 1987; 7(6):1799-808. PMC: 6568896. View